These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells. Batty IH, Fleming IN, Downes CP. Biochem J; 2004 May 01; 379(Pt 3):641-51. PubMed ID: 14769130 [Abstract] [Full Text] [Related]
9. Insulin signalling in skeletal muscle of subjects with or without Type II-diabetes and first degree relatives of patients with the disease. Meyer MM, Levin K, Grimmsmann T, Beck-Nielsen H, Klein HH. Diabetologia; 2002 Jun 01; 45(6):813-22. PubMed ID: 12107725 [Abstract] [Full Text] [Related]
13. Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Schwartz EA, Reaven PD. Endocrinol Metab Clin North Am; 2006 Sep 01; 35(3):525-49, viii. PubMed ID: 16959584 [Abstract] [Full Text] [Related]
14. Renal activity of Akt kinase in obese Zucker rats. Zdychová J, Kazdová L, Pelikanová T, Lindsley JN, Anderson S, Komers R. Exp Biol Med (Maywood); 2008 Oct 01; 233(10):1231-41. PubMed ID: 18641049 [Abstract] [Full Text] [Related]
15. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients. Bouzakri K, Roques M, Debard C, Berbe V, Rieusset J, Laville M, Vidal H. Diabetologia; 2004 Jul 01; 47(7):1314-23. PubMed ID: 15292987 [Abstract] [Full Text] [Related]
16. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways. Bibollet-Bahena O, Almazan G. J Neurochem; 2009 Jun 01; 109(5):1440-51. PubMed ID: 19453943 [Abstract] [Full Text] [Related]
17. Metformin: taking away the candy for cancer? Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, de Vries EG. Eur J Cancer; 2010 Sep 01; 46(13):2369-80. PubMed ID: 20656475 [Abstract] [Full Text] [Related]
18. Insulin resistance: pathophysiology and rationale for treatment. Muntoni S, Muntoni S. Ann Nutr Metab; 2011 Sep 01; 58(1):25-36. PubMed ID: 21304221 [Abstract] [Full Text] [Related]
19. Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models. LeRoith D. Diabetes Metab Res Rev; 2010 Nov 01; 26(8):599-601. PubMed ID: 20941806 [Abstract] [Full Text] [Related]
20. The emerging role of TRIB3 as a gene affecting human insulin resistance and related clinical outcomes. Prudente S, Morini E, Trischitta V. Acta Diabetol; 2009 Jun 01; 46(2):79-84. PubMed ID: 19139803 [Abstract] [Full Text] [Related] Page: [Next] [New Search]